Ajanta Pharma Ltd.

AJANTPHARM

₹2821.3

-2.04% (-58.8)

Market Cap

₹35,118 Cr.

P/E

34.61

Key Ratios

Edit Ratio's

Market cap

35,118 Cr

34.61

Prom Holding

66.25 %

ROE (%)

24.28

ROCE (%)

31.57

Div Yield (%)

Sales

5,201 Cr

OPM (%)

26.12 %

Debt to Equity

0.00

Edit Ratio's

About

Ajanta Pharma Limited is a specialty pharmaceuticals formulation company operating in India, A… Read more

Low

2327

52W Range

High

3021

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New

Edit rows

Forensics

13 Yes

Positive for this company

3 Neutral

Neutral for this company

1 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Depreciation Effect

Company is depreciating a greater percentage of assets. this is contributing to a reduction in net profit
Promoter Holding

Promoter has not sold any shares in the last 90 days

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
ROCE Strength

Roce of the company is consistently strong
ROE

Financial leverage has increased roe over 10 years
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Margin Stability

Margins of the company are volatile

Market Share

0.19 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.14 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

2.14 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

1.54 %

(as of Nov 21)

Historic

Dermatology - Market Share

0.01 %

(as of Jan 21)

Historic

Endocrinology - Market Share

0.02 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

0.01 %

(as of Apr 21)

Historic

Gynecology - Market Share

0.28 %

(as of Nov 21)

Historic

Neurological - Market Share

9.51 %

(as of Nov 21)

Historic

Ophthalmology - Market Share

0.66 %

(as of Nov 21)

Historic

Pain - Market Share

0.70 %

(as of Dec 22)

Historic

Pharmaceutical Sector - Market Share

0.14 %

(as of Nov 21)

Historic

Respiratory - Market Share

0 %

(as of Jul 22)

Historic

Sex Stimulants - Market Share

0.06 %

(as of Nov 21)

Historic

Stomatological - Market Share

0.17 %

(as of Nov 21)

Historic

Urology - Market Share

0.16 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Segment Break-Up

Therapeutic Area Wise Break-Up - Domestic

Branded Generics

Location Wise Break-Up

Asset Break-Up

Operational Metrics

Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

TCPL Packaging Ltd.
Kilitch Drugs (India) Ltd.
Haldyn Glass Ltd.

FAQs on Ajanta Pharma Ltd. Business

What does Ajanta Pharma do?

Ajanta Pharma Limited is a specialty pharmaceuticals formulation company with a diverse Branded Generics business in India, Asia, and Africa. They focus on chronic diseases, innovation, and have verticals in US Generics and Institutional business in Africa.

Who are the competitors of Ajanta Pharma?

Ajanta Pharma major competitors are Ipca Laboratories, Gland Pharma, JB Chem & Pharma, Glaxosmithkline Phar, Astrazeneca Pharma I, Wockhardt, Pfizer.
Market Cap of Ajanta Pharma is ₹34,821 Crs.
While the median market cap of its peers are ₹30,059 Crs.

Is Ajanta Pharma financially stable compared to its competitors?

Ajanta Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Jan Apr Jul Nov	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec
Investor Presentation		Jan Apr Jul Nov	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec
Conference Call		Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ajanta Pharma Ltd.

View the discussion on ValuePickr

Ajanta Pharma - What makes it special? - ValuePickr

Pharmaceuticals

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Ajanta Pharma Ltd.

Ajanta Pharma Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

13 Yes

3 Neutral

1 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Other Income

Pledge

Retail Holding

Revenue Recognition

Depreciation Effect

Promoter Holding

Price & Performance

Capex vs ROCE

Share price

Working Capital

Current vs Historic Valuation

Debt

Sales Growth

ROCE Strength

ROE

Balance Sheet Strength

Margin Stability

Market Share

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Segment Break-Up

UNLOCK PREMIUM

Therapeutic Area Wise Break-Up - Domestic

UNLOCK PREMIUM

Branded Generics

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Asset Break-Up

UNLOCK PREMIUM

Operational Metrics

Peer Comparison

Corporate Actions

Suppliers

FAQs on Ajanta Pharma Ltd. Business

What does Ajanta Pharma do?

Who are the competitors of Ajanta Pharma?

Is Ajanta Pharma financially stable compared to its competitors?

Similar Companies

Company Filing

Discussions & Analysis

SIGN UP FOR FREE